Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
about
Chemical chaperones exceed the chaperone effects of RIC-3 in promoting assembly of functional α7 AChRsNicotinic Activity of Arecoline, the Psychoactive Element of "Betel Nuts", Suggests a Basis for Habitual Use and Anti-Inflammatory ActivityThe smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumptionNeuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.Nicotinic receptor antagonists as treatments for nicotine abuse.The necessity of α4* nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine.Nicotine enhances inhibition of mouse vagal motor neurons by modulating excitability of premotor GABAergic neurons in the nucleus tractus solitarii.Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training.Functional characterization of the α5(Asn398) variant associated with risk for nicotine dependence in the α3β4α5 nicotinic receptor.Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtype.Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivoThe nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their study.Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variantChronic treatment with varenicline changes expression of four nAChR binding sites in mice.Enhanced Sensitivity of α3β4 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation.Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.Similar activity of mecamylamine stereoisomers in vitro and in vivoRecent advances in gene manipulation and nicotinic acetylcholine receptor biology.Discriminative Stimulus Properties of S(-)-Nicotine: "A Drug for All Seasons".Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation.Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.Cholinergic afferent stimulation induces axonal function plasticity in adult hippocampal granule cellsAssessment of the expression and role of the α1-nAChR subunit in efferent cholinergic function during the development of the mammalian cochlea.Mechanisms of facilitation of synaptic glutamate release by nicotinic agonists in the nucleus of the solitary tract.Cracking the Betel Nut: Cholinergic Activity of Areca Alkaloids and Related Compounds.
P2860
Q28486758-3F732C32-E1F0-41E6-AE57-AA7EF90E9D3CQ28550433-DF191CBA-8D77-48F9-B99A-844A671961B3Q30461965-C89F1B4E-EAD5-40E9-9CA8-CAF48521F075Q34137278-5FFE7BD0-5856-4074-A45D-9CB25C273396Q34342747-35AE8213-427B-4736-9DB1-36ACD4BF61EBQ34401397-07435094-2125-4E35-B821-498BB7640770Q34988448-92F15490-9AD8-4EBB-9411-AD9767F9F0BDQ35086342-D80489B2-00A5-483C-8C59-83EE37AAB72AQ35087469-A38B9002-3835-41D1-A278-C03BC13A9894Q35415808-456BAEF2-C7F5-4535-80AD-FEF2E33D65F8Q35790283-6309C8A2-FDB6-43E5-8FDB-543A0775653AQ35837691-C8296782-4F88-44C9-AFF8-DEB489BC58EEQ35972935-A310E22D-0809-48D0-B8F5-06D956F359A7Q36024696-ABF489AD-42E6-4E6B-9B1E-C77061643523Q36126982-F7B796BA-FD4E-424B-9790-39791CF49964Q36304857-662F0207-A0E4-42CF-9337-EB4BA21EC763Q36947767-8995CE5B-B005-43F1-88C5-B5E2B2E96D51Q37409561-83755739-721D-4E30-886E-E3ADDF5F09B1Q37712056-C0289379-2518-45D5-A95B-A2D2FB27C80EQ37894276-3A2D5E3D-13FA-4301-8A51-9E93FB892CCEQ38732951-DB076AFE-72B0-4D72-BB08-66EC1ECB0D17Q41283764-BAE2C8B5-06EF-4639-96A1-1552AC5055D0Q41817415-E6C1DE5C-3341-42D2-A959-CD8334B94EF7Q41901280-D1BF2421-4064-4412-90A5-D6D0F9F1CB98Q42369426-B41F5FE0-A033-4816-8E58-F593F2BFBD7DQ42863305-4D617F74-3C5C-46D8-983F-AB8A3331793CQ48510136-DC18A446-A033-41FF-97A7-95762161F385
P2860
Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation and inhibition of m ...... expressed in Xenopus oocytes.
@ast
Activation and inhibition of m ...... expressed in Xenopus oocytes.
@en
type
label
Activation and inhibition of m ...... expressed in Xenopus oocytes.
@ast
Activation and inhibition of m ...... expressed in Xenopus oocytes.
@en
prefLabel
Activation and inhibition of m ...... expressed in Xenopus oocytes.
@ast
Activation and inhibition of m ...... expressed in Xenopus oocytes.
@en
P2093
P2860
P356
P1476
Activation and inhibition of m ...... expressed in Xenopus oocytes.
@en
P2093
Jerry A Stitzel
Lynn Wecker
Roger L Papke
P2860
P304
P356
10.1124/JPET.109.164566
P407
P577
2010-01-25T00:00:00Z